ADVERTISEMENT

Accounting Firms

RSM advises Celadon Pharmaceuticals on £80m reverse acquisition

The acquisition means Celadon Pharmaceuticals plc has become the first pharmaceutical medicinal cannabis company to be admitted to AIM

ADVERTISEMENT

RSM UK has advised Celadon Pharmaceuticals plc on its £80m reverse acquisition of Vertigrow Technology Ltd.

Show More
Back to top button